` CDMO (Avid Bioservices Inc) vs S&P 500 Comparison - Alpha Spread

CDMO
vs
S&P 500

Over the past 12 months, CDMO has significantly outperformed S&P 500, delivering a return of 66% compared to the S&P 500's 9% growth.

Stocks Performance
CDMO vs S&P 500

Loading
CDMO
S&P 500
Add Stock

Performance Gap
CDMO vs S&P 500

Loading
CDMO
S&P 500
Difference
www.alphaspread.com

Performance By Year
CDMO vs S&P 500

Loading
CDMO
S&P 500
Add Stock

Competitors Performance
Avid Bioservices Inc vs Peers

S&P 500
CDMO
ABBV
AMGN
GILD
VRTX
Add Stock

Avid Bioservices Inc
Glance View

Market Cap
798.8m USD
Industry
Biotechnology

Avid Bioservices, Inc. engages in the commercial manufacturing. The company is headquartered in Tustin, California and currently employs 252 full-time employees. The firm is focused on development and Current Good Manufacturing Practices (CGMP) manufacturing of biopharmaceutical products derived from mammalian cell culture. The firm provides a range of process development, CGMP clinical and commercial manufacturing services for the biotechnology and biopharmaceutical industries. The Company’s services include CGMP clinical and commercial product manufacturing, purification, bulk packaging, stability testing and regulatory strategy, submission and support. The firm also provides process development activities, including cell line development and optimization, cell culture and feed optimization, analytical methods development and product characterization.

CDMO Intrinsic Value
8.6 USD
Overvaluation 31%
Intrinsic Value
Price
Back to Top